Each year, it is estimated more than 40,000 people will be diagnosed with liver cancer – and those numbers are increasing.

A new treatment option, Datroway (datopotamab deruxtecan or Dato-DXd), is now available for people with non-small cell lung ...

Research led by the Department of General and Visceral Surgery, Faculty of Medicine, University of Freiburg, Germany has ...

Scientists pinpoint cause of colon cancer in young peopleA 103-year-old marathon runner claims he halted the spread of his ...

Compared with colorectal cancer (CRC) presenting as an isolated primary or second primary malignancy, CRC presenting ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

To our knowledge, CONTACT-02 is the first phase 3 study of a tyrosine kinase inhibitor-immune checkpoint inhibitor combination to show a significant improvement in progression-free survival in ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

Liver metastasis can occur years after successful treatment of the primary cancer. A person should get regular checkups to help ensure they remain cancer-free.